Greg Lucier founded Corza Health in partnership with leading private equity firm GTCR to combine his 30+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities.
Greg most recently served as Chairman and CEO at NuVasive, a global technology leader in minimally invasive spine and orthopedic surgery. Prior to that, he was Chairman and CEO at Life Technologies—formerly Invitrogen—which he grew into a global life sciences powerhouse that was acquired by Thermo Fisher Scientific for more than $15 billion. He spent the first part of his career with the General Electric—including GE Healthcare—in a variety of corporate officer and executive roles.
Greg serves on several public and private company boards, including Antylia Scientific, Catalent, Dentsply Sirona, Maravai LifeSciences, and Pleno, Inc. He has been actively involved in a variety of community and civic engagements, including serving as the Chairperson for Sanford Burnham Research Institute in La Jolla, California and the Smithsonian Natural History Museum.
He holds a Bachelor’s in Industrial Engineering from Pennsylvania State University and a Master’s in Business Administration from Harvard Business School.
In his free time, Greg enjoys riding motorcycles—both on and off-road—as well as skiing. His family are proud supporters of the Lucier Fund for Engineering Equity at Penn State.